SCHEMBL1015659

SCHEMBL1015659

COC(=O)c1cc(Cl)ccc1NC(=O)COCC(=O)NCc1cccc(-c2ccsc2)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 3/20 0.60
PRMT6 Q96LA8 1/20 0.43
KDM4E B2RXH2 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.41
PLA2G1B P04054 1/20 0.41
HTT P42858 1/20 0.41
ATG4B Q9Y4P1 1/20 0.41
TRPM4 Q8TD43 1/20 0.41
CNR1 P21554 1/20 0.40
MAPT P10636 2/20 0.40
ANO1 Q5XXA6 1/20 0.40
PPARG P37231 1/20 0.40
PPARA Q07869 1/20 0.40
ADAMTS5 Q9UNA0 1/20 0.39
POLB P06746 2/20 0.39
THRB P10828 1/20 0.39
HPGD P15428 1/20 0.39
G6PD P11413 1/20 0.38
GAA P10253 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1013725 0.91 SERPINE1 (0.72) SERPINE1PRMT6KDM4EL3MBTL1PLA2G1B
SCHEMBL1013298 0.87 CNR1 (0.53) SERPINE1KDM4EL3MBTL1HTTTRPM4
SCHEMBL1015851 0.86 SERPINE1 (0.58) SERPINE1PRMT6KDM4EL3MBTL1PLA2G1B
SCHEMBL1015802 0.84 SERPINE1 (0.84) SERPINE1KDM4EL3MBTL1PLA2G1BHTT
SCHEMBL1015404 0.84 SERPINE1 (0.58) SERPINE1KDM4EL3MBTL1PLA2G1BHTT
SCHEMBL1015852 0.83 SERPINE1 (0.57) SERPINE1KDM4EL3MBTL1PLA2G1BHTT
SCHEMBL1015337 0.82 SERPINE1 (0.62) SERPINE1PRMT6KDM4EL3MBTL1PLA2G1B
SCHEMBL1017187 0.82 SERPINE1 (0.57) SERPINE1KDM4EL3MBTL1PLA2G1BHTT
SCHEMBL1013727 0.78 CNR1 (0.54) SERPINE1KDM4EL3MBTL1TRPM4CNR1
SCHEMBL1015582 0.77 SERPINE1 (0.69) SERPINE1PRMT6KDM4EL3MBTL1PLA2G1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415479-B2 Inhibitor of plasminogen activator inhibitor-1 RENASCIENCE CO., LTD. (JP) 2013-04-09 US disclosed
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 RENASCIENCE CO., LTD. (JP) 2011-05-12 US disclosed
EP-2272822-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 Renascience CO., LTD. (JP) 2011-01-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 SERPINE1, SERPINB1, SERPINC1 SERPINE1 1/4885PRMT6 1436/4885KDM4E 4108/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.